Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      CHMP Delivers Opinion on Translarna™ for Conversion to Full Authorization
      Biotech

      CHMP Delivers Opinion on Translarna™ for Conversion to Full Authorization

      September 15, 2023
      MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
      Biotech

      MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study

      September 15, 2023
      3D Cell Culture Market to grow by USD 1.28 billion from 2021 to 2026, North America to account for 41% of market growth- Technavio
      Biotech

      3D Cell Culture Market to grow by USD 1.28 billion from 2021 to 2026, North America to account for 41% of market growth- Technavio

      September 15, 2023
      Vial Announces Collaborative Alliance with MLM Medical Labs
      Biotech

      Vial Announces Collaborative Alliance with MLM Medical Labs

      September 15, 2023
      Dizal Announces China CDE Acceptance of New Drug Application for Golidocitinib for Relapsed or Refractory PTCL
      Biotech

      Dizal Announces China CDE Acceptance of New Drug Application for Golidocitinib for Relapsed or Refractory PTCL

      September 14, 2023
      Asieris’ New Drug APL-1401 Completes First Administration in Patient with Moderately to Severely Active UC
      Biotech

      Asieris’ New Drug APL-1401 Completes First Administration in Patient with Moderately to Severely Active UC

      September 14, 2023
      Nona Biosciences Expands Antibody Discovery Collaboration with BeiGene
      Biotech

      Nona Biosciences Expands Antibody Discovery Collaboration with BeiGene

      September 14, 2023
      Antimicrobial Resistance Market to Reach $9.5 Billion, Globally, by 2032 at 7.6% CAGR: Allied Market Research
      Biotech

      Antimicrobial Resistance Market to Reach $9.5 Billion, Globally, by 2032 at 7.6% CAGR: Allied Market Research

      September 14, 2023
      Dignify Therapeutics and Aayam Therapeutics enter into licensing agreement for novel on-demand defecation drug
      Biotech

      Dignify Therapeutics and Aayam Therapeutics enter into licensing agreement for novel on-demand defecation drug

      September 13, 2023
      Singleron launches AccuraCode® TCR library construction kit, enhancing efficiency and cost-effectiveness of high-throughput T-cell receptor profiling
      Biotech

      Singleron launches AccuraCode® TCR library construction kit, enhancing efficiency and cost-effectiveness of high-throughput T-cell receptor profiling

      September 13, 2023
      « 1 … 99 100 101 102 103 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026